公司简介

Applied Genetics Technologies develops cures for rare lung and eye diseases.

主要成员

Scott Koenig、Sue Washer、Terence Flotte、Richard Samulski、Barry Byrne

产品/服务

• 药物基因组
• 科技服务

Orphan Indications

Alpha-1 Antitrypsin Deficiency (Alpha 1), X-linked Retinoschisis (XLRS) and Achromatopsia (ACHM).

Gene therapy	Gene therapy replaces broken genes with normal functional genes, allowing a patient’s body to produce proteins to treat illness.
AAV	innovative delivery system.

融资信息

融资轮次	融资日期	投资方	融资额度
B轮	2003-11	未披露	$27M
天使轮	2009-06	InterWest Partners	$11.8M
援助	2010-09	未披露	$1M
债权融资	2012-05	未披露	$750K
B+轮	2012-11	Alta PartnersSR One	$37.5M

关联公司